Kaifeng Pharmaceutical (GROUP) Co., Ltd.
-
Founded in:
2003-09-26 -
Country:
China -
Address:
No. 1, Yunan Street, Kaifeng City -
Tax NO.:
914102007551588773 -
Registered Funds:
204.568562 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Triamcinolone acetonide 21-acetate |
Has anti-inflammatory, antipruritic and anti-allergic effects
More
Has anti-inflammatory, antipruritic and anti-allergic effects |
1mg | 3870-07-3 | 5 |
| Urea |
It has the function of dissolving and denaturing keratin and increasing the moisture of the stratum corneum, thus making the skin soft and preventing it from drying out.
More
It has the function of dissolving and denaturing keratin and increasing the moisture of the stratum corneum, thus making the skin soft and preventing it from drying out. |
100mg | 57-13-6 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Furazolidone |
|
67-45-8 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Piroxicam |
Extract from the above information
More
Extract from the above information |
36322-90-4 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Guaifenesin |
It can increase the secretion of respiratory glands, dilute sputum, and make it easier to cough up, thus producing an expectorant effect.
More
It can increase the secretion of respiratory glands, dilute sputum, and make it easier to cough up, thus producing an expectorant effect. |
93-14-1 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ISOPROPIRAMFUMARATE |
Activation inhibits the release of pain transmitters from the lateral cord, leading to hyperactivation of intrinsic factor, which binds to the U subtype opioid receptors and inhibits serotonin and norepinephrine, thereby eliminating the pain response.
More
Activation inhibits the release of pain transmitters from the lateral cord, leading to hyperactivation of intrinsic factor, which binds to the U subtype opioid receptors and inhibits serotonin and norepinephrine, thereby eliminating the pain response. |
84873-04-1 | 2 |